Clinical studies have demonstrated that GLP-1 receptor agonists can reduce various inflammatory biomarkers , including: C-reactive protein (CRP) : A general marker of systemic inflammation Interleukin-6 (IL-6) : A pro-inflammatory cytokine Tumour necrosis factor-alpha (TNF-) : Another key inflammatory mediator Plasminogen activator inhibitor-1 (PAI-1) : Associated with cardiovascular inflammation The magnitude of these effects varies between studies and may depend on baseline inflammatory status, degree of weight loss achieved, and individual patient characteristics
Justeen Griego, Owner / FNP-C We help people ages 15+ feel strong, confident, and vibrant through personalized medical, wellness, and aesthetic care
Patients who agreed to participate provided verbal consent
Who is a good candidate for lipotropic injections
Food & Drug Administration (FDA) added ileus warnings to Ozempic
Factors such as genetics, environment, and comorbidities can influence outcomes